Leaderboards/cardiomyopathy and myosin studies

cardiomyopathy and myosin studies

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Amara Greer-Short
Unknown
99
2
Hengzhi Du
World Wide Web Consortium
80
3
Ahmad Masri
Oregon Health & Science University
70
4
Christopher M. Kramer
University of Virginia
60
5
Yang Li
Ministry of Education of the People's Republic of China
50
6
Yulin Li
Ministry of Education of the People's Republic of China
40
7
Sheila M. Hegde
Brigham and Women's Hospital
30
8
Scott D. Solomon
Brigham and Women's Hospital
20
9
Hiroaki Kitaoka
Kōchi University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Constantin‐Cristian Topriceanu
MRC Unit for Lifelong Health and Ageing
99
2
Ahmad Masri
Oregon Health & Science University
90
3
Kristina B. Kooiker
Institute for Stem Cell Biology and Regenerative Medicine
80
4
Matteo Castrichini
Mayo Clinic
70
5
Massimo Buvoli
University of Colorado Boulder
60
6
Catherine G. Ireland
Brigham and Women's Hospital
50
7
Filip Rolski
Jagiellonian University
40
8
Soah Lee
Cardiovascular Institute of the South
30
9
Fengfeng Niu
Shenzhen University
20
10
Tania M. Larrinaga
University of Arizona
10

Emerging Leaders Papers

1
Lmod2 is necessary for effective skeletal muscle contraction
Science Advances|2024
12 cit.
2
A Laing distal myopathy–associated proline substitution in the β-myosin rod perturbs myosin cross-bridging activity
Journal of Clinical Investigation|2024
11 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Christine E. Seidman
Brigham and Women's Hospital
99
2
Mohamad H. Yamani
Unknown
90
3
Michel Komajda
Inserm
80
4
Ching-Pin Chang
Institute of Cardiology
70
5
Takehiko Sasazuki
Kyushu University
60
6
Douglas P. Zipes
Indiana University – Purdue University Indianapolis
50
7
Ching-Pin Chang
Stanford University
40
8
Ira J. Goldberg
Columbia University
20
9
Nava Epstein
University of Wisconsin–Madison
10

All-Time Leaders Papers

1
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment
European Heart Journal|2003
1.2k cit.
2
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
EP Europace|2011
899 cit.
3
Lipoprotein lipase
Journal of Lipid Research|2002
515 cit.
4
Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice
Journal of Clinical Investigation|2007
332 cit.
5
Endothelial cell CD36 optimizes tissue fatty acid uptake
Journal of Clinical Investigation|2018
252 cit.
6
Inhibition of c-Jun-N-terminal Kinase Increases Cardiac Peroxisome Proliferator-activated Receptor α Expression and Fatty Acid Oxidation and Prevents Lipopolysaccharide-induced Heart Dysfunction
Journal of Biological Chemistry|2011
102 cit.
7
DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle
Journal of Lipid Research|2011
79 cit.

Indexing cardiomyopathy and myosin studies Reagents

Citation data for reagents in this field is currently compiling.